Evening vs. morning dosing of blood pressure medication: no differences seen #ESCCongress #ESC24 #ESC2024
In two trials, one in frail elderly patients, evening administration of blood pressure (BP)-lowering medications had no clinical benefits over morning administration, according to late-breaking research presented in a Hot…
The antiviral tecovirimat is safe but did not improve Clade I #mpox resolution in Democratic Republic of the Congo DRC
The antiviral drug tecovirimat did not reduce the duration of mpox lesions among children and adults with clade I mpox in the Democratic Republic of the Congo (DRC), based on…
Immunotherapy approach shows potential in some people with metastatic solid tumors
Early findings from a small clinical trial provide evidence that a new cellular immunotherapy approach may be effective in treating metastatic solid tumors. In the trial, researchers from the National…
TUMORE DEL SENO: EVITARE IL BISTURI È POSSIBILE
Un’alta percentuale di pazienti con tumore al seno iniziale può evitare la chirurgia e ottenere lo stesso risultato oncologico grazie al trattamento percutaneo della crioablazione. È la conclusione attesa del…
Estrogen-Only Hormone Therapy may increase cancer risk while Estrogen-Progestin Combination may lower risk #ASCO24
For people who have been through menopause and have taken menopausal hormone therapy, conjugated equine estrogen (CEE) taken alone may increase the risk of developing and dying from ovarian cancer,…
NIH opens long COVID trials to evaluate treatments for autonomic nervous system dysfunction
Two phase 2 clinical trials to test the safety and effectiveness of three treatments for adults with autonomic nervous system dysfunction from long COVID have begun. The autonomic nervous system…
Tools underestimate cardiovascular event risk in people with HIV #CROI2024
The elevated cardiovascular disease risk among people with HIV is even greater than predicted by a standard risk calculator in several groups, including Black people and cisgender women, according to…